vs
FVCBankcorp, Inc.(FVCB)与SUTRO BIOPHARMA, INC.(STRO)财务数据对比。点击上方公司名可切换其他公司
FVCBankcorp, Inc.的季度营收约是SUTRO BIOPHARMA, INC.的1.5倍($16.9M vs $11.6M),FVCBankcorp, Inc.同比增速更快(4377.5% vs -21.4%),过去两年FVCBankcorp, Inc.的营收复合增速更高(586.6% vs -5.4%)
FVCBankcorp是总部位于美国弗吉尼亚州的银行控股公司,旗下运营社区银行FVCbank,面向大西洋中部地区的中小企业、专业人士及个人客户提供存款、贷款、按揭、财富管理等各类个人及商业银行金融服务。
Sutro Biopharma是一家上市生物科技公司,总部位于加州南旧金山,专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台,结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology,2009年改用现名。
FVCB vs STRO — 直观对比
营收规模更大
FVCB
是对方的1.5倍
$11.6M
营收增速更快
FVCB
高出4398.9%
-21.4%
两年增速更快
FVCB
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $16.9M | $11.6M |
| 净利润 | — | — |
| 毛利率 | — | — |
| 营业利润率 | 43.7% | — |
| 净利率 | — | — |
| 营收同比 | 4377.5% | -21.4% |
| 净利润同比 | — | 35.4% |
| 每股收益(稀释后) | $0.31 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FVCB
STRO
| Q4 25 | $16.9M | $11.6M | ||
| Q3 25 | $416.0K | $9.7M | ||
| Q2 25 | $15.8M | $63.7M | ||
| Q1 25 | $382.0K | $17.4M | ||
| Q4 24 | $378.0K | $14.8M | ||
| Q3 24 | $412.0K | $8.5M | ||
| Q2 24 | $415.0K | $25.7M | ||
| Q1 24 | $359.0K | $13.0M |
净利润
FVCB
STRO
| Q4 25 | — | — | ||
| Q3 25 | $5.6M | $-56.9M | ||
| Q2 25 | $5.7M | $-11.5M | ||
| Q1 25 | $5.2M | $-76.0M | ||
| Q4 24 | — | $-72.4M | ||
| Q3 24 | $4.7M | $-48.8M | ||
| Q2 24 | $4.2M | $-48.0M | ||
| Q1 24 | $1.3M | $-58.2M |
营业利润率
FVCB
STRO
| Q4 25 | 43.7% | — | ||
| Q3 25 | — | -499.9% | ||
| Q2 25 | 45.9% | -5.2% | ||
| Q1 25 | — | -393.8% | ||
| Q4 24 | — | -440.7% | ||
| Q3 24 | — | -797.2% | ||
| Q2 24 | — | -189.4% | ||
| Q1 24 | — | -435.0% |
净利率
FVCB
STRO
| Q4 25 | — | — | ||
| Q3 25 | 1341.1% | -586.6% | ||
| Q2 25 | 36.0% | -18.0% | ||
| Q1 25 | 1352.1% | -436.6% | ||
| Q4 24 | — | -489.2% | ||
| Q3 24 | 1133.3% | -572.6% | ||
| Q2 24 | 1001.2% | -186.8% | ||
| Q1 24 | 373.3% | -447.5% |
每股收益(稀释后)
FVCB
STRO
| Q4 25 | $0.31 | — | ||
| Q3 25 | $0.31 | $-0.67 | ||
| Q2 25 | $0.31 | $-0.14 | ||
| Q1 25 | $0.28 | $-0.91 | ||
| Q4 24 | $0.27 | $-27.63 | ||
| Q3 24 | $0.25 | $-0.59 | ||
| Q2 24 | $0.23 | $-0.59 | ||
| Q1 24 | $0.07 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $253.6M | $-132.5M |
| 总资产 | $2.3B | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
FVCB
STRO
| Q4 25 | — | $141.4M | ||
| Q3 25 | — | $167.6M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $249.0M | ||
| Q4 24 | — | $316.9M | ||
| Q3 24 | — | $388.3M | ||
| Q2 24 | — | $375.6M | ||
| Q1 24 | — | $267.6M |
股东权益
FVCB
STRO
| Q4 25 | $253.6M | $-132.5M | ||
| Q3 25 | $249.8M | $-87.3M | ||
| Q2 25 | $243.2M | $-32.1M | ||
| Q1 25 | $242.3M | $-25.8M | ||
| Q4 24 | $235.4M | $44.6M | ||
| Q3 24 | $230.8M | $111.2M | ||
| Q2 24 | $226.5M | $152.2M | ||
| Q1 24 | $220.7M | $98.0M |
总资产
FVCB
STRO
| Q4 25 | $2.3B | $173.8M | ||
| Q3 25 | $2.3B | $209.7M | ||
| Q2 25 | $2.2B | $262.4M | ||
| Q1 25 | $2.2B | $321.4M | ||
| Q4 24 | $2.2B | $387.2M | ||
| Q3 24 | $2.3B | $451.8M | ||
| Q2 24 | $2.3B | $489.0M | ||
| Q1 24 | $2.2B | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $23.9M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $23.8M | — |
| 自由现金流率自由现金流/营收 | 140.7% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.0M | — |
8季度趋势,按日历期对齐
经营现金流
FVCB
STRO
| Q4 25 | $23.9M | $-177.2M | ||
| Q3 25 | $7.6M | $-38.2M | ||
| Q2 25 | $3.3M | $-44.7M | ||
| Q1 25 | $5.4M | $-67.9M | ||
| Q4 24 | $18.2M | $-71.7M | ||
| Q3 24 | $4.7M | $-64.5M | ||
| Q2 24 | $1.6M | $9.5M | ||
| Q1 24 | $7.2M | $-64.7M |
自由现金流
FVCB
STRO
| Q4 25 | $23.8M | — | ||
| Q3 25 | $7.6M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $18.1M | — | ||
| Q3 24 | $4.6M | — | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $7.1M | — |
自由现金流率
FVCB
STRO
| Q4 25 | 140.7% | — | ||
| Q3 25 | 1818.0% | — | ||
| Q2 25 | 20.8% | — | ||
| Q1 25 | 1413.6% | — | ||
| Q4 24 | 4786.0% | — | ||
| Q3 24 | 1121.8% | — | ||
| Q2 24 | 361.2% | — | ||
| Q1 24 | 1988.3% | — |
资本支出强度
FVCB
STRO
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 14.1% | — | ||
| Q2 24 | 12.8% | — | ||
| Q1 24 | 3.9% | — |
现金转化率
FVCB
STRO
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 5.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图